Cubist Pharmaceuticals, Inc. Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has awarded nearly $300,000 in grants this year to benefit 16 organizations with science, technology, engineering, and mathematics (STEM) programs in Massachusetts. These grants reflect the company’s ongoing commitment to STEM education, with an emphasis on supporting programs for underserved middle- and high-school students in Massachusetts. As Cubist celebrates its 20th anniversary this month, it also marks the fifth year of its philanthropic program focused on supporting nonprofit organizations with STEM education initiatives. Since 2008, Cubist has awarded more than $1 million to STEM programs.